|
【结 构 式】 
|
【分子编号】43278 【品名】9-amino-3-(cyclohexylmethoxy)-6,7,8,9-tetrahydro-5H-benzo[a]cycloheptene-2-carboxamide 【CA登记号】 |
【 分 子 式 】C19H28N2O2 【 分 子 量 】316.4436 【元素组成】C 72.12% H 8.92% N 8.85% O 10.11% |
合成路线1
该中间体在本合成路线中的序号：(XI)Treatment of 6,7,8,9-tetrahydro-5H-benzocyclohepten-2-ol (I) with (bromomethyl)cyclohexane (II) in the presence of Cs2CO3 provided the cyclohexylmethyl ether (III). Regioselective oxidation of (III) by means potassium persulfate gave ketone (IV), which was reduced to alcohol (V) with NaBH4. Azide (VI) was obtained by treatment of alcohol (V) with diphenylphosphoryl azide. Catalytic hydrogenation of azide (VI) in the presence of Boc2O furnished the tert-butyl carbamate (VII). Aromatic bromination of (VII) with N-bromosuccinimide provided bromide (VIII) which, upon lithiation and subsequent quenching with CO2, gave rise to carboxylic acid (IX). Amide (X) was prepared by treatment of acid (IX) with ammonium hydroxide in the presence of EDC and HOBt. The Boc protecting group of (X) was then removed using trifluoroacetic acid to give (XI).
| 【1】 Bohacek, R.; Sawyer, T.K.; Yang, M.G.; Eyermann, C.J.; Sundaramoorthi, R.; Shakespeare, W.C. (Ariad Pharmaceuticals Inc.); Bicyclic signal transduction inhibitors, compsns. containing them & uses thereof. WO 0027802 . |
| 中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
|---|---|---|---|---|---|---|
| (I) | 43269 | 6,7,8,9-tetrahydro-5H-benzo[a]cyclohepten-2-ol | C11H14O | 详情 | 详情 | |
| (II) | 31767 | 1-(bromomethyl)cyclohexane | 2550-36-9 | C7H13Br | 详情 | 详情 |
| (III) | 43270 | 2-(cyclohexylmethoxy)-6,7,8,9-tetrahydro-5H-benzo[a]cycloheptene; cyclohexylmethyl 6,7,8,9-tetrahydro-5H-benzo[a]cyclohepten-2-yl ether | C18H26O | 详情 | 详情 | |
| (IV) | 43271 | 2-(cyclohexylmethoxy)-6,7,8,9-tetrahydro-5H-benzo[a]cyclohepten-5-one | C18H24O2 | 详情 | 详情 | |
| (V) | 43272 | 2-(cyclohexylmethoxy)-6,7,8,9-tetrahydro-5H-benzo[a]cyclohepten-5-ol | C18H26O2 | 详情 | 详情 | |
| (VI) | 43273 | 5-azido-6,7,8,9-tetrahydro-5H-benzo[a]cyclohepten-2-yl cyclohexylmethyl ether; 5-azido-2-(cyclohexylmethoxy)-6,7,8,9-tetrahydro-5H-benzo[a]cycloheptene | C18H25N3O | 详情 | 详情 | |
| (VII) | 43274 | tert-butyl 2-(cyclohexylmethoxy)-6,7,8,9-tetrahydro-5H-benzo[a]cyclohepten-5-ylcarbamate | C23H35NO3 | 详情 | 详情 | |
| (VIII) | 43275 | tert-butyl 3-bromo-2-(cyclohexylmethoxy)-6,7,8,9-tetrahydro-5H-benzo[a]cyclohepten-5-ylcarbamate | C23H34BrNO3 | 详情 | 详情 | |
| (IX) | 43276 | 9-[(tert-butoxycarbonyl)amino]-3-(cyclohexylmethoxy)-6,7,8,9-tetrahydro-5H-benzo[a]cycloheptene-2-carboxylic acid | C24H35NO5 | 详情 | 详情 | |
| (X) | 43277 | tert-butyl 3-(aminocarbonyl)-2-(cyclohexylmethoxy)-6,7,8,9-tetrahydro-5H-benzo[a]cyclohepten-5-ylcarbamate | C24H36N2O4 | 详情 | 详情 | |
| (XI) | 43278 | 9-amino-3-(cyclohexylmethoxy)-6,7,8,9-tetrahydro-5H-benzo[a]cycloheptene-2-carboxamide | C19H28N2O2 | 详情 | 详情 |
合成路线2
该中间体在本合成路线中的序号：(XI)L-3-Formyl-N-acetyltyrosine methyl ester (XII) was protected as the dithioacetal (XIII) using ethanedithiol and boron trifluoride etherate. After conversion of the phenol group of (XIII) into aryl triflate (XIV) upon treatment with N-phenyltrifluoromethanesulfonimide, its carboxylation with carbon monoxide in MeOH-DMSO in the presence of palladium catalyst generated the methyl ester (XV). Selective hydrolysis of the aliphatic ester of (XV) with LiOH at low temperature provided carboxylic acid (XVI), which was then coupled with the racemic amine (XI) to afford amide (XVII) as a diastereomeric mixture. Hydrolysis of the thioketal group of (XVII) to give aldehyde (XVIII) was achieved by treatment with mercuric perchlorate. The remaining methyl ester of (XVIII) was hydrolyzed with LiOH, and the desired diastereoisomer was finally isolated by RP-HPLC.
| 【1】 Bohacek, R.S.; Rickles, R.J.; Barlet, C.; Holt, D.A.; Guan, W.; Smith, J.A.; Baron, R.; Sawyer, T.K.; Violette, S.M.; Shakespeare, W.C.; A Src SH2 selective binding compound inhibits osteoclast-mediated resorption. Chem Biol 2000, 7, 3, 225. |
| 【2】 Bohacek, R.; Sawyer, T.K.; Yang, M.G.; Eyermann, C.J.; Sundaramoorthi, R.; Shakespeare, W.C. (Ariad Pharmaceuticals Inc.); Bicyclic signal transduction inhibitors, compsns. containing them & uses thereof. WO 0027802 . |
| 中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
|---|---|---|---|---|---|---|
| (XI) | 43278 | 9-amino-3-(cyclohexylmethoxy)-6,7,8,9-tetrahydro-5H-benzo[a]cycloheptene-2-carboxamide | C19H28N2O2 | 详情 | 详情 | |
| (XII) | 44905 | methyl (2S)-2-(acetamido)-3-(3-formyl-4-hydroxyphenyl)propanoate | C13H15NO5 | 详情 | 详情 | |
| (XIII) | 44906 | methyl (2S)-2-(acetamido)-3-[3-(1,3-dithiolan-2-yl)-4-hydroxyphenyl]propanoate | C15H19NO4S2 | 详情 | 详情 | |
| (XIV) | 44907 | methyl (2S)-2-(acetamido)-3-(3-(1,3-dithiolan-2-yl)-4-[[(trifluoromethyl)sulfonyl]oxy]phenyl)propanoate | C16H18F3NO6S3 | 详情 | 详情 | |
| (XV) | 44908 | methyl 4-[(2S)-2-(acetamido)-3-methoxy-3-oxopropyl]-2-(1,3-dithiolan-2-yl)benzoate | C17H21NO5S2 | 详情 | 详情 | |
| (XVI) | 44909 | (2S)-2-(acetamido)-3-[3-(1,3-dithiolan-2-yl)-4-(methoxycarbonyl)phenyl]propionic acid | C16H19NO5S2 | 详情 | 详情 | |
| (XVII) | 44910 | methyl 4-((2S)-2-(acetamido)-3-[[3-(aminocarbonyl)-2-(cyclohexylmethoxy)-6,7,8,9-tetrahydro-5H-benzo[a]cyclohepten-5-yl]amino]-3-oxopropyl)-2-(1,3-dithiolan-2-yl)benzoate | C35H45N3O6S2 | 详情 | 详情 | |
| (XVIII) | 44911 | methyl 4-((2S)-2-(acetamido)-3-[[3-(aminocarbonyl)-2-(cyclohexylmethoxy)-6,7,8,9-tetrahydro-5H-benzo[a]cyclohepten-5-yl]amino]-3-oxopropyl)-2-formylbenzoate | C33H41N3O7 | 详情 | 详情 |
合成路线3
该中间体在本合成路线中的序号：(XVI)Condensation of 6,7,8,9-tetrahydro-5H-benzocyclohepten-2-ol (VI) with (bromomethyl)cyclohexane (VII) in the presence of Cs2CO3 gave ether (VIII). Benzylic oxidation of (VIII) to provide ketone (IX) was effected by treatment with potassium persulfate in the presence of cupric sulfate. Subsequent reduction of (IX) with NaBH4 yielded alcohol (X), which was converted to azide (XI) using diphenylphosphoryl azide and DBU. Catalytic hydrogenation of the azido group of (XI) in the presence of Boc2O produced carbamate (XII). Bromination of (XII) at position 3 was carried out by means of N-bromosuccinimide in acetonitrile. The resulting aryl bromide (XIII) was lithiated with butyllithium in cold THF and subsequently converted to carboxylic acid (XIV) by quenching with CO2 gas. Coupling of acid (XIV) with ammonia by means of EDC and HOBt afforded amide (XV). The Boc group of (XV) was then removed by treatment with trifluoroacetic acid to furnish the racemic amine (XVI).
| 【1】 Bohacek, R.; Sawyer, T.K.; Yang, M.G.; Eyermann, C.J.; Sundaramoorthi, R.; Shakespeare, W.C. (Ariad Pharmaceuticals Inc.); Bicyclic signal transduction inhibitors, compsns. containing them & uses thereof. WO 0027802 . |
| 中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
|---|---|---|---|---|---|---|
| (VI) | 43269 | 6,7,8,9-tetrahydro-5H-benzo[a]cyclohepten-2-ol | C11H14O | 详情 | 详情 | |
| (VII) | 31767 | 1-(bromomethyl)cyclohexane | 2550-36-9 | C7H13Br | 详情 | 详情 |
| (VIII) | 43270 | 2-(cyclohexylmethoxy)-6,7,8,9-tetrahydro-5H-benzo[a]cycloheptene; cyclohexylmethyl 6,7,8,9-tetrahydro-5H-benzo[a]cyclohepten-2-yl ether | C18H26O | 详情 | 详情 | |
| (IX) | 43271 | 2-(cyclohexylmethoxy)-6,7,8,9-tetrahydro-5H-benzo[a]cyclohepten-5-one | C18H24O2 | 详情 | 详情 | |
| (X) | 43272 | 2-(cyclohexylmethoxy)-6,7,8,9-tetrahydro-5H-benzo[a]cyclohepten-5-ol | C18H26O2 | 详情 | 详情 | |
| (XI) | 43273 | 5-azido-6,7,8,9-tetrahydro-5H-benzo[a]cyclohepten-2-yl cyclohexylmethyl ether; 5-azido-2-(cyclohexylmethoxy)-6,7,8,9-tetrahydro-5H-benzo[a]cycloheptene | C18H25N3O | 详情 | 详情 | |
| (XII) | 43274 | tert-butyl 2-(cyclohexylmethoxy)-6,7,8,9-tetrahydro-5H-benzo[a]cyclohepten-5-ylcarbamate | C23H35NO3 | 详情 | 详情 | |
| (XIII) | 43275 | tert-butyl 3-bromo-2-(cyclohexylmethoxy)-6,7,8,9-tetrahydro-5H-benzo[a]cyclohepten-5-ylcarbamate | C23H34BrNO3 | 详情 | 详情 | |
| (XIV) | 43276 | 9-[(tert-butoxycarbonyl)amino]-3-(cyclohexylmethoxy)-6,7,8,9-tetrahydro-5H-benzo[a]cycloheptene-2-carboxylic acid | C24H35NO5 | 详情 | 详情 | |
| (XV) | 43277 | tert-butyl 3-(aminocarbonyl)-2-(cyclohexylmethoxy)-6,7,8,9-tetrahydro-5H-benzo[a]cyclohepten-5-ylcarbamate | C24H36N2O4 | 详情 | 详情 | |
| (XVI) | 43278 | 9-amino-3-(cyclohexylmethoxy)-6,7,8,9-tetrahydro-5H-benzo[a]cycloheptene-2-carboxamide | C19H28N2O2 | 详情 | 详情 |
合成路线4
该中间体在本合成路线中的序号：(XVI)Coupling of carboxylic acid (V) with either the racemic amine (XVI) or the chiral amine (XXIV) in the presence of EDC and HOBt, followed by trifluoroacetic acid-promoted cleavage of the Boc group, furnished the diastereomeric mixture of amides (XXV) or the pure (S,S)-isomer (XXVI), respectively. Isomer (XXVI) was also obtained by separation of the diastereomeric mixture (XXV) by means of preparative reverse-phase HPLC. Acetylation of the amino group of (XXVI) with acetic anhydride gave amide (XXVII). Finally, the ethyl phosphonate esters of (XXVII) were hydrolyzed by means of trimethylsilyl iodide in acetonitrile.
| 【1】 Bohacek, R.; Yang, M.; Shakespeare, W.; et al.; Structure-based design of an osteoclast-selective, nonpeptide Src homology 2 inhibitor with in vivo antiresorptive activity. Proceedings of the National Academy of Sciences of the United States of America 2000, 97, 17, 9373. |
| 【2】 Bohacek, R.; Sawyer, T.K.; Yang, M.G.; Eyermann, C.J.; Sundaramoorthi, R.; Shakespeare, W.C. (Ariad Pharmaceuticals Inc.); Bicyclic signal transduction inhibitors, compsns. containing them & uses thereof. WO 0027802 . |
| 中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
|---|---|---|---|---|---|---|
| (V) | 43286 | (9S)-9-amino-3-(cyclohexylmethoxy)-6,7,8,9-tetrahydro-5H-benzo[a]cycloheptene-2-carboxamide | C19H28N2O2 | 详情 | 详情 | |
| (XVI) | 43278 | 9-amino-3-(cyclohexylmethoxy)-6,7,8,9-tetrahydro-5H-benzo[a]cycloheptene-2-carboxamide | C19H28N2O2 | 详情 | 详情 | |
| (XXIV) | 43268 | (2S)-3-[3,4-bis(diethoxyphosphoryl)phenyl]-2-[(tert-butoxycarbonyl)amino]propionic acid | C22H37NO10P2 | 详情 | 详情 | |
| (XXV) | 43287 | diethyl 4-((2S)-2-amino-3-[[3-(aminocarbonyl)-2-(cyclohexylmethoxy)-6,7,8,9-tetrahydro-5H-benzo[a]cyclohepten-5-yl]amino]-3-oxopropyl)-2-(diethoxyphosphoryl)phenylphosphonate | C36H55N3O9P2 | 详情 | 详情 | |
| (XXVI) | 43288 | diethyl 4-((2S)-2-amino-3-[[(5S)-3-(aminocarbonyl)-2-(cyclohexylmethoxy)-6,7,8,9-tetrahydro-5H-benzo[a]cyclohepten-5-yl]amino]-3-oxopropyl)-2-(diethoxyphosphoryl)phenylphosphonate | C36H55N3O9P2 | 详情 | 详情 | |
| (XXVII) | 43289 | diethyl 4-((2S)-2-(acetamido)-3-[[(5S)-3-(aminocarbonyl)-2-(cyclohexylmethoxy)-6,7,8,9-tetrahydro-5H-benzo[a]cyclohepten-5-yl]amino]-3-oxopropyl)-2-(diethoxyphosphoryl)phenylphosphonate | C38H57N3O10P2 | 详情 | 详情 |